<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04604197</url>
  </required_header>
  <id_info>
    <org_study_id>EPIC23-ANGELINE</org_study_id>
    <nct_id>NCT04604197</nct_id>
  </id_info>
  <brief_title>ANGiographic Evaluation of Left Main Coronary Artery INtErvention</brief_title>
  <acronym>ANGELINE</acronym>
  <official_title>ANGiographic Evaluation of Left Main Coronary Artery INtErvention</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fundación EPIC</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fundación EPIC</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To assess if an angiographic follow-up at 6 months after Percutaneous Coronary Intervention&#xD;
      in Left Main Coronary Artery Disease decrease the composite objective of death, myocardial&#xD;
      infarction, and stroke at 36 months.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Percutaneous coronary intervention (PCI) with drug-eluting stents in left main (LM) disease&#xD;
      has demonstrated similar results than surgical revascularization in patients with SYNTAX&#xD;
      score &lt; 33, being the main drawback of PCI a higher rate of new revascularization. A small&#xD;
      study found a reduction in the composite end-point of cardiac death, myocardial infarction&#xD;
      and urgent revascularization with a routine angiographic follow-up. The investigators have&#xD;
      designed a prospective, randomized, controlled, two-arm multicenter study in patients aged&#xD;
      18-85 with LM disease and SYNTAX score &lt;33 and in cases ≥ 33 based on the Heart Team decision&#xD;
      to assess the benefit of a routine angiographic follow-up 6 months after LM stenting. After&#xD;
      the index procedure and before hospital discharge the patient will be randomized to routine&#xD;
      invasive angiographic follow-up at 6 months plus clinical follow-up at 6 months, 1, 2 and 3&#xD;
      years vs. the control arm, which would be followed clinically at 6 months, 1, 2 and 3 years.&#xD;
      Based on our calculations, an adequately powered trial would require 1009 patients per arm&#xD;
      but due to the uncertainty of the results and the current economical restrictions we have&#xD;
      designed a pilot study in 400 patients to find out the convenience of an adequately powered&#xD;
      trial. All the lesions should be treated with an everolimus eluting stent with permanent&#xD;
      fluoropolymer. It will be desirable to achieve complete revascularization and it will be&#xD;
      highly recommended to perform the procedures guided with an intravascular image technique&#xD;
      (OCT or IVUS (IntraVascular UltraSound) according to operator´s criteria). The main outcome&#xD;
      will be death, myocardial infarction and cerebrovascular accident at 3 years. The initial&#xD;
      percutaneous technique and the decision about the convenience and way of revascularization in&#xD;
      case of restenosis in the follow-up will be left at the operator´s discretion, according in&#xD;
      the most adequate way to the current guidelines. Nonetheless, the investigators are strongly&#xD;
      encouraged to rely on intravascular techniques, based on either imaging or physiology. In&#xD;
      those cases with in-stent hyperplasia with doubts about possible restenosis, FFR and RFR&#xD;
      (Resting full-cycle ratio) will be performed, with low threshold to achieve a high rate of&#xD;
      ruling out the restenosis.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 16, 2021</start_date>
  <completion_date type="Anticipated">December 1, 2025</completion_date>
  <primary_completion_date type="Anticipated">December 1, 2025</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Composite endpoint: defined as : death, myocardial infarction, and stroke.</measure>
    <time_frame>36 months</time_frame>
    <description>Composite endpoint: defined as : death, myocardial infarction, and stroke.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>All Death</measure>
    <time_frame>36 months</time_frame>
    <description>Occurrence of Death</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cardiac Death</measure>
    <time_frame>36 months</time_frame>
    <description>Occurrence of Cardiac Death</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Myocardial Infarction</measure>
    <time_frame>36 months</time_frame>
    <description>Occurrence of Myocardial Infarction</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stroke</measure>
    <time_frame>36 months</time_frame>
    <description>Occurrence of Stroke</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stent thrombosis (ARC definite/probable)</measure>
    <time_frame>36 months</time_frame>
    <description>Occurrence of thrombosis (ARC definite/probable)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Major bleeding event (BARC type 2-5)</measure>
    <time_frame>36 months</time_frame>
    <description>Occurrence of Major bleeding event (BARC type 2-5)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Target Vessel revascularization.</measure>
    <time_frame>36 months</time_frame>
    <description>Occurrence of Target Vessel revascularization.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Revascularization by CABG ( Coronary Artery Bypass Grafting) or PCI (Percutaneous Coronary Intervention)</measure>
    <time_frame>36 months</time_frame>
    <description>Occurrence of New revascularization by CABG or PCI</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">400</enrollment>
  <condition>Coronary Occlusion</condition>
  <condition>Left Main Coronary Artery Disease</condition>
  <condition>Coronary Artery Stenosis</condition>
  <condition>Coronary Disease</condition>
  <condition>Coronary Artery Disease</condition>
  <arm_group>
    <arm_group_label>Angiography and Clinical Follow up</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>After PCI. The patient is randomized to an angiographic follow-up at 6 months and a Clinical Follow to 36 months</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Clinical Follow up</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>After PCI. The patient is randomized to a Clinical Follow to 36 months</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Angiography and Clinical Follow up</intervention_name>
    <description>Angiography and Clinical Follow up</description>
    <arm_group_label>Angiography and Clinical Follow up</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Clinical Follow up</intervention_name>
    <description>Clinical Follow up</description>
    <arm_group_label>Clinical Follow up</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age: 18- 85 years at the date of the PCI.&#xD;
&#xD;
          -  With PCI for presenting de novo lesions in the Left Main Artery by implanting a&#xD;
             cobalt-chrome stent with everolimus-eluting fluoropolymer.&#xD;
&#xD;
          -  Informed consent signed.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Refusal to participate in the study.&#xD;
&#xD;
          -  Myocardial infarction with ST-segment elevation on current admission.&#xD;
&#xD;
          -  Previous coronary surgery.&#xD;
&#xD;
          -  Creatinine clearance &lt;40 ml / min.&#xD;
&#xD;
          -  Contraindication for double antiaggregation after PCI.&#xD;
&#xD;
          -  Patients life expectancy &lt;36 months.&#xD;
&#xD;
          -  Included in other studies or clinical trials.&#xD;
&#xD;
          -  Pregnant or lactating women.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Iñigo Lozano, MD, PhD</last_name>
    <phone>+34987876135</phone>
    <email>ilozano@fundacionepic.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Fundacion Epic</last_name>
    <phone>+34987876135</phone>
    <email>iepic@fundacionepic.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hospital Universitario de Cruces</name>
      <address>
        <city>Barakaldo</city>
        <state>Bizkaia</state>
        <zip>48903</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Donostia</name>
      <address>
        <city>Donostia</city>
        <state>Gipuzkoa</state>
        <zip>20014</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hospital Galdakao-Usansolo</name>
      <address>
        <city>Galdakao</city>
        <state>Vizcaya</state>
        <zip>48960</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hospital General Universitario de Albacete</name>
      <address>
        <city>Albacete</city>
        <zip>02006</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hospital General Universitario de Alicante</name>
      <address>
        <city>Alicante</city>
        <zip>03010</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hospital Universitari Vall D'Hebron</name>
      <address>
        <city>Barcelona</city>
        <zip>08035</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hospital Universitari Bellvitge</name>
      <address>
        <city>Barcelona</city>
        <zip>08907</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario de Ciudad Real</name>
      <address>
        <city>Ciudad Real</city>
        <zip>13005</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario de A Coruña</name>
      <address>
        <city>Coruña</city>
        <zip>15006</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Reina Sofia</name>
      <address>
        <city>Córdoba</city>
        <zip>14004</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario de Cabueñes</name>
      <address>
        <city>Gijón</city>
        <zip>33394</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Virgen de Las Nieves</name>
      <address>
        <city>Granada</city>
        <zip>18014</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hospital General Juan Ramón Jiménez</name>
      <address>
        <city>Huelva</city>
        <zip>21005</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario de León</name>
      <address>
        <city>León</city>
        <zip>24071</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario 12 de Octubre</name>
      <address>
        <city>Madrid</city>
        <zip>28041</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario La Paz</name>
      <address>
        <city>Madrid</city>
        <zip>28046</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Virgen Arrixaca</name>
      <address>
        <city>Murcia</city>
        <zip>30120</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Marques de Valdecilla</name>
      <address>
        <city>Santander</city>
        <zip>39008</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hospital Clínico Universitario de Santiago de Compostela</name>
      <address>
        <city>Santiago De Compostela</city>
        <zip>15706</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hospital Clinico Universitario de Valencia</name>
      <address>
        <city>Valencia</city>
        <zip>46010</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hospital Clinico Universitario de Valladolid</name>
      <address>
        <city>Valladolid</city>
        <zip>47003</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hospital Clinico Universitario Lozano Blesa</name>
      <address>
        <city>Zaragoza</city>
        <zip>50009</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Miguel Servet</name>
      <address>
        <city>Zaragoza</city>
        <zip>50009</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <reference>
    <citation>Cavalcante R, Sotomi Y, Lee CW, Ahn JM, Farooq V, Tateishi H, Tenekecioglu E, Zeng Y, Suwannasom P, Collet C, Albuquerque FN, Onuma Y, Park SJ, Serruys PW. Outcomes After Percutaneous Coronary Intervention or Bypass Surgery in Patients With Unprotected Left Main Disease. J Am Coll Cardiol. 2016 Sep 6;68(10):999-1009. doi: 10.1016/j.jacc.2016.06.024.</citation>
    <PMID>27585503</PMID>
  </reference>
  <reference>
    <citation>Puri R, de la Torre Hernandez JM, Auffret V. Routine Surveillance Coronary Angiography Post-PCI: Should We ReACT and Change Our Routine? JACC Cardiovasc Interv. 2017 Jan 23;10(2):118-120. doi: 10.1016/j.jcin.2016.11.020. Epub 2016 Dec 28.</citation>
    <PMID>28040444</PMID>
  </reference>
  <reference>
    <citation>Aurigemma C, Burzotta F, Porto I, Niccoli G, Leone AM, Crea F, Trani C. Clinical impact of routine angiographic follow-up after percutaneous coronary interventions on unprotected left main. Cardiol J. 2018;25(5):582-588. doi: 10.5603/CJ.a2018.0092. Epub 2018 Aug 29.</citation>
    <PMID>30155864</PMID>
  </reference>
  <reference>
    <citation>Stone GW, Sabik JF, Serruys PW, Simonton CA, Généreux P, Puskas J, Kandzari DE, Morice MC, Lembo N, Brown WM 3rd, Taggart DP, Banning A, Merkely B, Horkay F, Boonstra PW, van Boven AJ, Ungi I, Bogáts G, Mansour S, Noiseux N, Sabaté M, Pomar J, Hickey M, Gershlick A, Buszman P, Bochenek A, Schampaert E, Pagé P, Dressler O, Kosmidou I, Mehran R, Pocock SJ, Kappetein AP; EXCEL Trial Investigators. Everolimus-Eluting Stents or Bypass Surgery for Left Main Coronary Artery Disease. N Engl J Med. 2016 Dec 8;375(23):2223-2235. Epub 2016 Oct 31. Erratum in: N Engl J Med. 2019 Oct 31;381(18):1789.</citation>
    <PMID>27797291</PMID>
  </reference>
  <reference>
    <citation>Mäkikallio T, Holm NR, Lindsay M, Spence MS, Erglis A, Menown IB, Trovik T, Eskola M, Romppanen H, Kellerth T, Ravkilde J, Jensen LO, Kalinauskas G, Linder RB, Pentikainen M, Hervold A, Banning A, Zaman A, Cotton J, Eriksen E, Margus S, Sørensen HT, Nielsen PH, Niemelä M, Kervinen K, Lassen JF, Maeng M, Oldroyd K, Berg G, Walsh SJ, Hanratty CG, Kumsars I, Stradins P, Steigen TK, Fröbert O, Graham AN, Endresen PC, Corbascio M, Kajander O, Trivedi U, Hartikainen J, Anttila V, Hildick-Smith D, Thuesen L, Christiansen EH; NOBLE study investigators. Percutaneous coronary angioplasty versus coronary artery bypass grafting in treatment of unprotected left main stenosis (NOBLE): a prospective, randomised, open-label, non-inferiority trial. Lancet. 2016 Dec 3;388(10061):2743-2752. doi: 10.1016/S0140-6736(16)32052-9. Epub 2016 Oct 31. Erratum in: Lancet. 2016 Dec 3;388(10061):2742.</citation>
    <PMID>27810312</PMID>
  </reference>
  <reference>
    <citation>Stone GW, Kappetein AP, Sabik JF, Pocock SJ, Morice MC, Puskas J, Kandzari DE, Karmpaliotis D, Brown WM 3rd, Lembo NJ, Banning A, Merkely B, Horkay F, Boonstra PW, van Boven AJ, Ungi I, Bogáts G, Mansour S, Noiseux N, Sabaté M, Pomar J, Hickey M, Gershlick A, Buszman PE, Bochenek A, Schampaert E, Pagé P, Modolo R, Gregson J, Simonton CA, Mehran R, Kosmidou I, Généreux P, Crowley A, Dressler O, Serruys PW; EXCEL Trial Investigators. Five-Year Outcomes after PCI or CABG for Left Main Coronary Disease. N Engl J Med. 2019 Nov 7;381(19):1820-1830. doi: 10.1056/NEJMoa1909406. Epub 2019 Sep 28. Erratum in: N Engl J Med. 2020 Mar 12;382(11):1078.</citation>
    <PMID>31562798</PMID>
  </reference>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>October 21, 2020</study_first_submitted>
  <study_first_submitted_qc>October 21, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">October 27, 2020</study_first_posted>
  <last_update_submitted>October 19, 2021</last_update_submitted>
  <last_update_submitted_qc>October 19, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 20, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Angiography</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
    <mesh_term>Coronary Stenosis</mesh_term>
    <mesh_term>Coronary Occlusion</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

